Advanced search
Publication Cover
Infection and Drug Resistance Volume 11, 2018 - Issue
Submit an article Journal homepage
43
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Effect of ethanol pretreatment in Acanthamoeba keratitis: a long-term follow-up study

I-Huang Lin1 Department of Ophthalmology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China
,
Sung-Huei Tseng1 Department of Ophthalmology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China
,
Fu-Chin Huang1 Department of Ophthalmology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China
&
Yi-Hsun Huang1 Department of Ophthalmology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China;2 Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of ChinaCorrespondence[email protected]
Pages 937-943 | Published online: 05 Jul 2018

References

  • Awwad ST, Petroll WM, McCulley JP, Cavanagh HD. Updates in Acanthamoeba keratitis. Eye Contact Lens. 2007;33(1):1–8.
  • Joslin CE, Tu EY, Shoff ME, et al. The association of contact lens solution use and Acanthamoeba keratitis. Am J Ophthalmol. 2007;144(2):169–180.
  • Tu EY, Joslin CE. Recent outbreaks of atypical contact lens-related keratitis: what have we learned? Am J Ophthalmol. 2010;150(5):602–608.e602.
  • Jiang C, Sun X, Wang Z, Zhang Y. Acanthamoeba keratitis: clinical characteristics and management. Ocul Surf. 2015;13(2):164–168.
  • Sarnicola E, Sarnicola C, Sabatino F, Tosi GM, Perri P, Sarnicola V. Early deep anterior lamellar keratoplasty (DALK) for Acanthamoeba keratitis poorly responsive to medical treatment. Cornea. 2016;35(1):1–5.
  • Ortilles A, Belloc J, Rubio E, et al. In-vitro development of an effective treatment for Acanthamoeba keratitis. Int J Antimicrob Agents. 2017;50(3):325–333.
  • Tu EY, Joslin CE, Shoff ME. Successful treatment of chronic stromal Acanthamoeba keratitis with oral voriconazole monotherapy. Cornea. 2010;29(9):1066–1068.
  • Lorenzo-Morales J, Khan NA, Walochnik J. An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment. Parasite. 2015;22:10.
  • Huang FC, Liu TS, Li SC, Shih MH, Shin JW, Lin WC. The effect of the disulfideisomerase domain containing protein in the defense against polyhexamethylene biguanide of highly tolerant Acanthamoeba at the trophozoite stage. Int J Parasitol Drugs Drug Resist. 2016;6(3):251–257.
  • Robaei D, Carnt N, Minassian DC, Dart JK. Therapeutic and optical keratoplasty in the management of Acanthamoeba keratitis: risk factors, outcomes, and summary of the literature. Ophthalmology. 2015;122(1):17–24.
  • Holland GN, Donzis PB. Rapid resolution of early Acanthamoeba keratitis after epithelial debridement. Am J Ophthalmol. 1987;104(1):87–89.
  • Li ML, Shih MH, Huang FC, Tseng SH, Chen CC. Treatment of early Acanthamoeba keratitis with alcohol-assisted epithelial debridement. Cornea. 2012;31(4):442–446.
  • Tu EY, Joslin CE, Sugar J, Shoff ME, Booton GC. Prognostic factors affecting visual outcome in Acanthamoeba keratitis. Ophthalmology. 2008;115(11):1998–2003.
  • Brooks JG Jr, Coster DJ, Badenoch PR. Acanthamoeba keratitis. Resolution after epithelial debridement. Cornea. 1994;13(2):186–189.
  • O’Keefe M, Kirwan C. Laser epithelial keratomileusis in 2010 – a review. Clin Experiment Ophthalmol. 2010;38(2):183–191.
  • Aqeel Y, Rodriguez R, Chatterjee A, Ingalls RR, Samuelson J. Killing of diverse eye pathogens (Acanthamoeba spp., Fusarium solani, and Chlamydia trachomatis) with alcohols. PLoS Negl Trop Dis. 2017;11(2):e0005382.
  • Ezz Eldin HM, Sarhan RM. Cytotoxic effect of organic solvents and surfactant agents on Acanthamoeba castellanii cysts. Parasitol Res. 2014;113(5):1949–1953.
  • Por YM, Mehta JS, Chua JL, et al. Acanthamoeba keratitis associated with contact lens wear in Singapore. Am J Ophthalmol. 2009;148(1):7–12.e12.
  • Chew HF, Yildiz EH, Hammersmith KM, et al. Clinical outcomes and prognostic factors associated with Acanthamoeba keratitis. Cornea. 2011;30(4):435–441.
  • Qian Y, Meisler DM, Langston RH, Jeng BH. Clinical experience with Acanthamoeba keratitis at the cole eye institute, 1999–2008. Cornea. 2010;29(9):1016–1021.
  • Park DH, Palay DA, Daya SM, Stulting RD, Krachmer JH, Holland EJ. The role of topical corticosteroids in the management of Acanthamoeba keratitis. Cornea. 1997;16(3):277–283.
  • Illingworth CD, Cook SD, Karabatsas CH, Easty DL. Acanthamoeba keratitis: risk factors and outcome. Br J Ophthalmol. 1995;79(12):1078–1082.
  • Maycock NJ, Jayaswal R. Update on Acanthamoeba keratitis: diagnosis, treatment, and outcomes. Cornea. 2016;35(5):713–720.
  • Yamazoe K, Yamamoto Y, Shimazaki-Den S, Shimazaki J. Visual outcome in Japanese patients with Acanthamoeba keratitis. Eye. 2012;26(4):517–522.
  • Lee MH, Abell RG, Mitra B, Ferdinands M, Vajpayee RB. Risk factors, demographics and clinical profile of Acanthamoeba keratitis in Melbourne: an 18-year retrospective study. Br J Ophthalmol. 2017;102(5):687–691.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.